These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8206482)

  • 1. High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.
    Tanaka M; Kumazawa J; Matsumoto T; Kobayashi I
    Genitourin Med; 1994 Apr; 70(2):90-3. PubMed ID: 8206482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
    Melby K; Faegri A
    APMIS; 1989 Apr; 97(4):347-50. PubMed ID: 2497756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
    Tanaka M; Tunoe H; Mochida O; Kanayama A; Saika T; Kobayashi I; Naito S
    Diagn Microbiol Infect Dis; 2000 Oct; 38(2):109-13. PubMed ID: 11035242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan.
    Tanaka M; Matsumoto T; Kobayashi I; Uchino U; Kumazawa J
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2367-70. PubMed ID: 8619601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
    Knapp JS; Hale JA; Neal SW; Wintersheid K; Rice RJ; Whittington WL
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2442-5. PubMed ID: 8585723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 May; 43(18):325-7. PubMed ID: 8164636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic susceptibility pattern of gonococcal isolates.
    Jain SK; Kulkarni MG; Banker DD
    Indian J Med Sci; 1994 Oct; 48(10):233-6. PubMed ID: 7829173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993.
    Knapp JS; Washington JA; Doyle LJ; Neal SW; Parekh MC; Rice RJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2194-6. PubMed ID: 7811045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
    Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics sensitivity pattern of N. gonorrhoeae with special emphasis on norfloxacin and ciprofloxacin.
    Pai A; Kulkarni MG; Koppikar GV
    J Assoc Physicians India; 1999 Aug; 47(8):795-7. PubMed ID: 10778625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii.
    Knapp JS; Ohye R; Neal SW; Parekh MC; Higa H; Rice RJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2200-3. PubMed ID: 7811047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones.
    Deguchi T; Saito I; Tanaka M; Sato K; Deguchi K; Yasuda M; Nakano M; Nishino Y; Kanematsu E; Ozeki S; Kawada Y
    Sex Transm Dis; 1997 May; 24(5):247-50. PubMed ID: 9153731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991-1999.
    Trees DL; Sandul AL; Neal SW; Higa H; Knapp JS
    Sex Transm Dis; 2001 Jun; 28(6):309-14. PubMed ID: 11403186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.
    Akasaka S; Muratani T; Yamada Y; Inatomi H; Takahashi K; Matsumoto T
    J Infect Chemother; 2001 Mar; 7(1):49-50. PubMed ID: 11406757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of predominant Neisseria gonorrhoeae strain types and its correlation with fluoroquinolone resistance in Pakistan.
    Nizamuddin S; Jabeen K; Zafar A
    J Pak Med Assoc; 2011 May; 61(5):446-9. PubMed ID: 22204176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoea and decrease of in vitro susceptibility to quinolones over time in Rwanda.
    Bogaerts J; Tello WM; Akingeneye J; Mukantabana V; Van Dyck E; Piot P
    Genitourin Med; 1993 Jun; 69(3):196-200. PubMed ID: 8335312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activities of OPC-17116, ofloxacin, and ciprofloxacin against 200 isolates of Neisseria gonorrhoeae.
    Zenilman JM; Neumann T; Patton M; Reichart C
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2244-6. PubMed ID: 8257153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic susceptibility of Neisseria gonorrhoeae epidemic strains in Changsha].
    Zou MX; Xia ZD; Liang XH
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):53-5. PubMed ID: 12934399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological characterisation of Neisseria gonorrhoeae by co-agglutination technique.
    Kulkarni MG; Roche RA; Jain S; Murti PK
    J Assoc Physicians India; 1993 Jun; 41(6):352-3. PubMed ID: 8005971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.
    Carlyn CJ; Doyle LJ; Knapp CC; Ludwig MD; Washington JA
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1606-8. PubMed ID: 7492114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.